相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis
Marta Magaz et al.
JOURNAL OF HEPATOLOGY (2021)
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
David P. Al-Adra et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Overview of Myeloproliferative Neoplasms History, Pathogenesis, Diagnostic Criteria, and Complications
Douglas Tremblay et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)
Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases
Patrick G. Northup et al.
HEPATOLOGY (2021)
Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation
Snjezana Janjetovic et al.
THROMBOSIS RESEARCH (2021)
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients
Tiziano Barbui et al.
LEUKEMIA (2021)
Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability
Li Wang et al.
DISEASE MODELS & MECHANISMS (2021)
TIPS for Adults Without Cirrhosis With Chronic Mesenteric Venous Thrombosis and EHPVO Refractory to Standard-of-Care Therapy
Gabriel M. Knight et al.
HEPATOLOGY (2021)
Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience
Douglas Tremblay et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis
Alberto Alvarez-Larran et al.
ANNALS OF HEMATOLOGY (2020)
The utility of thrombophilia testing in patients with newly diagnosed portal vein thrombosis
Douglas Tremblay et al.
BLOOD COAGULATION & FIBRINOLYSIS (2020)
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation
Leonard Naymagon et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis
Michael Praktiknjo et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
Johanne Poisson et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Venous thrombosis of the liver: current and emerging concepts in management
Leonard Naymagon
TRANSLATIONAL RESEARCH (2020)
Anticoagulant therapy for splanchnic vein thrombosis ISTH SSC Subcommittee Control of Anticoagulation
Marcello Di Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses
Pierre-Edouard Debureaux et al.
BLOOD ADVANCES (2020)
Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
Melissa Castiglione et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase
Vikas Gupta et al.
BLOOD ADVANCES (2020)
The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis
Leonard Naymagon et al.
BLOOD ADVANCES (2020)
Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis
Amr Shaaban Hanafy et al.
VASCULAR PHARMACOLOGY (2019)
Vascular endothelial cell expression of JAK2(V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy et al.
HAEMATOLOGICA (2019)
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis
J. Mascarenhas et al.
LEUKEMIA (2019)
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome A Randomized Noninferiority Trial
Josep Ordi-Ros et al.
ANNALS OF INTERNAL MEDICINE (2019)
Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm
Ricardo Helman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study
Malin Hultcrantz et al.
ANNALS OF INTERNAL MEDICINE (2018)
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbuil et al.
LEUKEMIA (2018)
Rivaroxaban and Apixaban for Initial Treatment of Acute Venous Thromboembolism of Atypical Location
Dawid T. Janczak et al.
MAYO CLINIC PROCEEDINGS (2018)
Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis
Miaomiao Li et al.
THROMBOSIS RESEARCH (2018)
Clinical manifestations and imaging tools in the diagnosis of splanchnic and cerebral vein thromboses
Nicoletta Riva et al.
THROMBOSIS RESEARCH (2018)
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall et al.
THROMBOSIS AND HAEMOSTASIS (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hydroxyurea prevents arterial and late venous thrombotic recurrences in patients with myeloproliferative neoplasms but fails in the splanchnic venous district. Pooled analysis of 1500 cases
Valerio De Stefano et al.
BLOOD CANCER JOURNAL (2018)
Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases
Sravanthi Lavu et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study
Johanne Poisson et al.
JOURNAL OF HEPATOLOGY (2017)
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
K. I. Ataga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
STAT3 activation in endothelial cells is important for tumor metastasis via increased cell adhesion molecule expression
K-J Kim et al.
ONCOGENE (2017)
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms
Lisa Pieri et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo
Junliang Pan et al.
BLOOD (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Guidance for the management of venous thrombosis in unusual sites
Walter Ageno et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2016)
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients
V. De Stefano et al.
BLOOD CANCER JOURNAL (2016)
Distinct Clinical, Laboratory, and Molecular Features of Myeloproliferative Neoplasm Patients Presenting with Splanchnic Vein Thrombosis
Joan How et al.
BLOOD (2016)
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis
Umberto Gianelli et al.
LEUKEMIA RESEARCH (2015)
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors
S. Cerquozzi et al.
BLOOD CANCER JOURNAL (2015)
Percutaneous Mesocaval Shunt Creation in a Patient with Chronic Portal and Superior Mesenteric Vein Thrombosis
Zachary L. Bercu et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis
Raajit Rampal et al.
BLOOD (2014)
Selected parameters of hemostasis in patients with myeloproliferative neoplasms
Grazyna Gadomska et al.
BLOOD COAGULATION & FIBRINOLYSIS (2014)
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia vera
Federico Lussana et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Nitric oxide scavenging by cell-free hemoglobin may be a primary factor determining hypertension in polycythemic patients
T. Rusak et al.
FREE RADICAL RESEARCH (2014)
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
A. Tefferi et al.
LEUKEMIA (2014)
Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
Vittorio Rosti et al.
BLOOD (2013)
CANCER-ASSOCIATED THROMBOTIC DISEASE Myeloproliferative neoplasms and thrombosis
Tiziano Barbui et al.
BLOOD (2013)
Good Long-Term Outcome of Budd-Chiari Syndrome With a Step-wise Management
Susana Seijo et al.
HEPATOLOGY (2013)
Age-related differences in disease characteristics and clinical outcomes in polycythemia vera
Brady L. Stein et al.
LEUKEMIA & LYMPHOMA (2013)
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Thorsten Klampfl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Multivisceral Transplantation for Diffuse Portomesenteric Thrombosis
Rodrigo M. Vianna et al.
ANNALS OF SURGERY (2012)
Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation
Kit Man Wong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis
Jasper H. Smalberg et al.
BLOOD (2012)
Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms
J. Hoekstra et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Mesenteric venous thrombosis
Ian G. Harnik et al.
VASCULAR MEDICINE (2010)
Etiology, Management, and Outcome of the Budd-Chiari Syndrome
Sarwa Darwish Murad et al.
ANNALS OF INTERNAL MEDICINE (2009)
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
Selcuk Sozer et al.
BLOOD (2009)
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
Jean-Jacques Kiladjian et al.
BLOOD (2008)
Portal Hypertension-Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation
Juan Turnes et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
TIPS for Budd-Chiari syndrome:: Long-term results and prognostics factors in 124 patients
Juan Carlos Garcia-Pagan et al.
GASTROENTEROLOGY (2008)
Eighteen years of liver transplantation experience in patients with advanced Budd-Chiari syndrome
Frank Ulrich et al.
LIVER TRANSPLANTATION (2008)
Venous thrombosis in oral contraceptive users and the presence of the JAK2V617F mutation
Elvira Grandone et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
Massimo Primignani et al.
HEPATOLOGY (2006)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Elevated soluble urokinase plasminogen activator receptor in plasma from patients with idiopathic myelofibrosis or polycythaemia vera
MK Jensen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2002)
Mesenteric venous thrombosis: Diagnosis and noninvasive imaging
MS Bradbury et al.
RADIOGRAPHICS (2002)
分享论文
